Clinical Trial Update: Study of Efficacy and Safety of ABO809 in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and preliminary efficacy of ABO809 in healthy participants has been completed. Results have been posted; the study listed Cr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptosporidiosis
• Cryptosporidium Infection

Drugs mentioned

• ABO809

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cryptosporidium Infection, Cryptosporidiosis | Phase 1 | Status: COMPLETED | Results posted: 2024-10-02